ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,796,101 | -24.0% | 287,255 | -13.9% | 0.15% | -30.3% |
| Q2 2023 | $10,256,985 | -23.7% | 333,669 | -10.6% | 0.22% | -14.3% |
| Q1 2023 | $13,443,514 | -14.9% | 373,120 | -6.7% | 0.26% | -1.1% |
| Q4 2022 | $15,803,258 | -3.7% | 399,880 | -2.1% | 0.26% | -20.9% |
| Q3 2022 | $16,415,000 | -13.9% | 408,546 | -9.9% | 0.33% | -17.3% |
| Q2 2022 | $19,067,000 | +25.2% | 453,556 | +16.0% | 0.40% | +30.0% |
| Q1 2022 | $15,230,000 | +35.3% | 390,918 | +38.4% | 0.31% | +23.8% |
| Q4 2021 | $11,259,000 | +29.6% | 282,537 | +17.6% | 0.25% | +22.2% |
| Q3 2021 | $8,685,000 | -0.6% | 240,328 | +12.7% | 0.20% | +14.0% |
| Q2 2021 | $8,741,000 | +302.6% | 213,257 | +328.5% | 0.18% | +263.3% |
| Q1 2021 | $2,171,000 | – | 49,765 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |